Hospital
Reedsburg Area Medical Center, INC.
Reedsburg Area Medical Center, INC. was paid $13.72M by Medicaid between Jan 2018 and Dec 2024, across 181 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 15% of everything it billed.
33Billing provider infoREEDSBURG AREA MEDICAL CENTER, INC.
REEDSBURG, WI 53959
REEDSBURG, WI 53959
33aNPI1891796710assigned 08/02/2005
33bProvider typeCritical Access Hospital
28Total paid$13.72M
24GClaims301,655
24DCodes billed181
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Wisconsin
Rank by total paid#3 of 48
Median peer was paid$4.30M
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,922 | $1.41M | |
| 2019 | 33,153 | $1.45M | |
| 2020 | 32,678 | $1.47M | |
| 2021 | 49,271 | $2.26M | |
| 2022 | 51,354 | $2.57M | |
| 2023 | 56,878 | $2.61M | |
| 2024incomplete | 45,399 | $1.95M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 15% | 4,305 | 3,163 | $2.05M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 9,381 | 7,743 | $1.79M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11% | 7,497 | 6,356 | $1.47M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.2% | 7,225 | 5,639 | $1.27M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5.6% | 3,647 | 1,897 | $762K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.7% | 3,739 | 2,918 | $641K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.8% | 4,340 | 2,033 | $520K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.6% | 1,666 | 1,479 | $497K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.5% | 1,700 | 1,499 | $474K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 3,278 | 2,999 | $275K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.7% | 7,634 | 4,504 | $231K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.6% | 765 | 651 | $217K |
169 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 2,634 | $215K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 8,914 | $210K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.2% | 3,960 | $161K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.0% | 1,202 | $140K |
| 80053 | Comprehensive metabolic panel | <1% | 14,131 | $136K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 348 | $135K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 733 | $128K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,356 | $119K |
| 87632 | <1% | 733 | $117K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,442 | $113K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 467 | $93K |
| 73630 | <1% | 2,111 | $81K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,072 | $75K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,631 | $72K |
| 59025 | Fetal non-stress test | <1% | 276 | $71K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 182 | $68K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,836 | $61K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 172 | $56K |
| 80061 | Lipid panel | <1% | 4,323 | $54K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 422 | $54K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,764 | $52K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,559 | $49K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,525 | $47K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,741 | $46K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,675 | $41K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,050 | $40K |
| 73610 | <1% | 975 | $37K | |
| G0378 | Hospital observation service, per hour | <1% | 624 | $37K |
| 76830 | Ultrasound, transvaginal | <1% | 222 | $36K |
| 76801 | <1% | 290 | $34K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,456 | $33K |
| 97162 | <1% | 976 | $32K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,625 | $32K |
| 85027 | <1% | 5,637 | $31K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,817 | $31K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,928 | $27K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 187 | $26K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,047 | $24K |
| 84484 | <1% | 4,003 | $24K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 732 | $22K |
| 73562 | <1% | 600 | $21K | |
| 82728 | <1% | 1,622 | $20K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 297 | $20K |
| 83880 | <1% | 1,255 | $20K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 281 | $19K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 395 | $18K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 356 | $18K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 865 | $18K |
| 11721 | <1% | 3,837 | $17K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 284 | $17K |
| 83690 | <1% | 3,396 | $16K | |
| 81025 | <1% | 2,242 | $16K | |
| 80050 | General health panel | <1% | 1,014 | $16K |
| 93356 | <1% | 44 | $16K | |
| 81000 | <1% | 4,767 | $15K | |
| 83605 | <1% | 2,778 | $15K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 56 | $15K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 713 | $14K |
| 82962 | <1% | 2,627 | $13K | |
| 87077 | <1% | 2,091 | $13K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 783 | $13K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 42 | $12K |
| 87081 | <1% | 1,628 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,398 | $12K |
| 85610 | <1% | 2,830 | $11K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 218 | $11K |
| 87186 | <1% | 1,827 | $11K | |
| 83735 | <1% | 2,575 | $10K | |
| 86850 | <1% | 1,316 | $10K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 343 | $10K |
| 87808 | <1% | 764 | $10K | |
| 84702 | <1% | 645 | $9K | |
| 73030 | <1% | 273 | $9K | |
| 80306 | <1% | 619 | $8K | |
| 87070 | <1% | 908 | $7K | |
| 87905 | <1% | 767 | $7K | |
| 86803 | <1% | 596 | $7K | |
| 84703 | <1% | 820 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 71 | $7K |
| 82077 | <1% | 733 | $6K | |
| 84145 | <1% | 536 | $6K | |
| 86618 | <1% | 226 | $6K | |
| 86780 | <1% | 576 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 705 | $5K |
| 83550 | <1% | 736 | $5K | |
| 87040 | <1% | 1,025 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,957 | $5K |
| 82607 | <1% | 392 | $5K | |
| 84439 | <1% | 561 | $5K | |
| 83540 | <1% | 810 | $5K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 356 | $4K |
| 82570 | <1% | 934 | $4K | |
| 86140 | <1% | 1,062 | $4K | |
| 87220 | <1% | 867 | $4K | |
| 87653 | <1% | 101 | $4K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,963 | $4K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 28 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,834 | $3K |
| 0352U | <1% | 320 | $3K | |
| 85379 | <1% | 525 | $3K | |
| 87340 | <1% | 326 | $3K | |
| 81001 | <1% | 1,350 | $3K | |
| 86900 | <1% | 1,086 | $3K | |
| 92567 | <1% | 57 | $3K | |
| 86901 | <1% | 1,087 | $2K | |
| 73502 | <1% | 67 | $2K | |
| 73130 | <1% | 74 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,336 | $2K |
| 81003 | <1% | 1,316 | $2K | |
| 93017 | <1% | 17 | $2K | |
| 86762 | <1% | 150 | $2K | |
| 80076 | <1% | 249 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 14 | $2K |
| 73110 | <1% | 46 | $1K | |
| 82043 | <1% | 306 | $1K | |
| 85730 | <1% | 409 | $1K | |
| 97166 | <1% | 37 | $1K | |
| 80179 | <1% | 108 | $885.13 | |
| 85651 | <1% | 330 | $878.70 | |
| 80143 | <1% | 111 | $874.10 | |
| 82803 | <1% | 66 | $808.20 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 17 | $658.06 |
| 97163 | <1% | 18 | $641.12 | |
| 87205 | <1% | 237 | $601.98 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,489 | $551.35 |
| 97161 | <1% | 15 | $528.48 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 17 | $502.74 |
| 84153 | <1% | 30 | $447.92 | |
| 82950 | <1% | 76 | $446.93 | |
| 84481 | <1% | 28 | $415.50 | |
| 36000 | <1% | 102 | $395.22 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,965 | $328.43 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,584 | $325.53 |
| 85652 | <1% | 208 | $317.80 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,699 | $308.69 |
| 86787 | <1% | 42 | $277.78 | |
| 87185 | <1% | 96 | $268.92 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,437 | $230.13 |
| 93041 | <1% | 464 | $212.38 | |
| 81002 | <1% | 64 | $190.47 | |
| 83655 | <1% | 13 | $182.12 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,808 | $180.92 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 48 | $178.24 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,405 | $160.01 |
| J3490 | Unclassified drugs | <1% | 12 | $150.64 |
| 84460 | <1% | 14 | $139.05 | |
| 96376 | <1% | 862 | $137.04 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 993 | $76.63 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,224 | $76.39 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,732 | $52.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 83 | $51.74 |
| 80320 | <1% | 221 | $25.80 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 965 | $24.61 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 545 | $18.87 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 293 | $9.10 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 318 | $5.14 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 513 | $4.07 |
| Q9962 | High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml | <1% | 15 | $2.16 |
| A9270 | Non-covered item or service | 0% | 6,041 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 60 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 26 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 28 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 13 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 15 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 13 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 79 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 12 | $0.00 |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | 0% | 17 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVAN MEETEREN, ROBERT (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Reedsburg Area Medical Center | Reedsburg, WI | $14K |
| Reedsburg Area Medical Center | Reedsburg, WI | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.